DNA breakage due to metronidazole treatment

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 478, Issue 1-2, 2001, Pages 153-158

  Menendez D ^a   Rojas, E ^a   Herrera, L A ^a,c   Lopez M C ^a   Sordo, M ^a   Elizondo, G ^b   Ostrosky Wegman, P ^a  

^a INSTITUTO DE INVESTIGACIONES BIOMÉDICAS   (Mexico)

^b DEPARTAMENTO DE FÍSICA   (Mexico)

^c INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

Author keywords

Antiparasitic drugs; Comet assay; DNA repair

Indexed keywords

METRONIDAZOLE;

ADULT; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DNA STRAND BREAKAGE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EXPOSURE; GENOTOXICITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; MONONUCLEAR CELL; MUTAGENIC ACTIVITY; NORMAL HUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CELL SURVIVAL; COMET ASSAY; DNA; DNA DAMAGE; HUMANS; LYMPHOCYTES; MALE; METRONIDAZOLE;

PROKARYOTA;

EID: 0035400259     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(01)00136-1     Document Type: Article

References (38)

1. Activitiè de 1′-(hydroxy-2-ethyl)-1-methyl-2-nitro-5-imidazole (8.823R.P.) vis-a-vis des infections expérimentales àTrichomonas vaginalis
2. Metronidazole in gardiasis
3. Metronidazole in amoebic dysentery and hepatic liver abscess
4. Treatment of anaerobic infections with MTZ
5. Helicobacter pylori eradication: Efficacy and side effects profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens
6. Metronidazole uptake in Helicobacter pylori
7. On the mutagenicity of nitroimidazoles
8. Comparasion of the genetic activity of 5-nitroimidazole derivates in Escherichia coli, Neurospora crassa, Saccharomyces cerevisae and Drosophila melanogaster
9. Mutagenicity of a series of 25-nitroimidazoles and two nitrothiazoles in Salmonella thypimurium
10. Genotoxicity in oxazolidine derivates: Influence of the nitro group
11. Evaluation of the mutagenic and genotoxic activities of 48-nitroimidazoles and related imidazole derivatives by the Ames test and the SOS chromotest
12. Nitroimidazoles durgs - Action and resistance mechanisms. I. Mechanisms of action
13. Genotoxicity and carcinogenicity of metronidazole
14. Validity of in vitro testing
15. Interaction of metronidazole with nucleic acids in vitro
16. Reduction of nitroimidazoles and DNA damage
17. DNA single strand-breaks in lymphocytes after metronidazole therapy
18. Metronidazole induces DNA strand-breaks in cultures of human lymphocytes and phytohemagglutinin-stimulated human lymphocytes
19. Comparision of the sensitivity of human and rat hepatocytes to the genotoxic effects of metronidazole
20. Metronidazole hprt mutation induction in sheep and the relationship whit its elimination rate
21. + ATPase systems in cultured mammalian cells
22. Absence of genotoxic effects of metronidazole and two of its urinary metabolites in human lymphocytes in vitro
23. Mutagenic bioassay of certain pharmacological drugs. III. Metronidazole (MTZ)
24. Chromosome aberrations and metronidazole
25. Chromosome studies of bone marrow cells from metronidazole treated patients
26. No cytogenetic effect of metronidazole
27. Metronidazole exhibits no clastogenic activity in a double blind cross over study on Crohn's patients
28. Evaluation of the genotoxic activity of metronidazole and dimetridazole in human lymphocytes by the comet assay
29. Reinvestigation of in vivo genotoxicity studies in man. I. No induction of DNA strand breaks in peripheral lymphocytes after metronidazole therapy
30. Genotoxic effects of metronidazole
31. 2 and gamma radiation with the alkaline comet assay
32. Biological significance of DNA damage by hyperbaric oxygen
33. Single cell gel electrophoresis assay: Methodology and applications
34. Determination of metronidazole and tinidazole in plasma and feces by high performance liquid chromatography
35. Metronidazole and antipyrine as probes for the study of foreign compound metabolism
36. Influence of doseand route of administration on disposition of metronidazole and its metabolites
37. The influence of metronidazole and its two main metabolites on murine in vitro lymphocytes transformation
38. The contribution of metronidazole and two metabolites to the mutagenic activity detected in urine of treated humans and mice